For media inquiries, please contact press@allazohealth.com
New York, NY – AllazoHealth is pleased to announce that Founder and CTO Clifford Jones and CEO William Grambley have been recognized as ELITE 2023 Entrepreneurs by PM360, a leading journal for pharmaceutical marketing professionals.…
Read More
NEW YORK, December 15, 2023 — AllazoHealth, the pioneer in delivering AI-driven healthcare experiences, has been selected by PM360 as part of its prestigious annual Innovations Issue, which highlights the most forward-thinking advancements in the…
NEW YORK, April 24, 2023—Getting and keeping patients engaged in their medication support programs is key to ensuring therapy initiation, adherence, and positive outcomes. And delivering personalized interactions at the individual patient level is proven to be the best way to drive engagement.
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation.
NEW YORK, December 15, 2023 — AllazoHealth, the pioneer in delivering AI-driven healthcare experiences, has been selected by PM360 as part of its prestigious annual Innovations Issue, which highlights the most forward-thinking advancements in the…
Read moreNew York, NY – AllazoHealth is pleased to announce that Founder and CTO Clifford Jones and CEO William Grambley have been recognized as ELITE 2023 Entrepreneurs by PM360, a leading journal for pharmaceutical marketing professionals.…
Read moreNEW YORK, April 24, 2023—Getting and keeping patients engaged in their medication support programs is key to ensuring therapy initiation, adherence, and positive outcomes. And delivering personalized interactions at the individual patient level is proven to be the best way to drive engagement.
Read moreNew York, NY (April 23, 2019) – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as Vice President of Customer Success.
Read moreAllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation.
Read moreAllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board.
Read moreNew York, NY – AllazoHealth announced today that William Grambley will take on the position of Chief Executive Officer after serving more than two years as Chief Operating Officer at the fast-growing healthcare AI company.…
Read moreIn the Fall 2019 edition of BioSupply Trends Quarterly, AllazoHealth CEO William Grambley shares how artificial intelligence (AI) will change the healthcare landscape. “There are so many places where AI is impacting people’s lives that…
Read moreNEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on ensuring optimal patient outcomes, today announced
Read moreAllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina.
Read moreDownload our infographic to learn how manufacturers can drive patient behaviors for better therapy initiation, adherence, and health outcomes using AI-powered personalization at the individual level.
Download InfographicExplore our comprehensive media kit that’s been curated to provide the AllazoHealth experience. Delve into a diverse array of content such as logos, headshots, content, and the latest news that showcases the depth and breadth of our offerings.
Download Media Kit